All News

Pharmacy Society of Wisconsin backs state budget bill that would boost dispensing fee and hold pharmacists harmless if the average manufacturer price rule takes affect.

NextWave Pharmaceuticals and Kerr Drug to provide MyKidz Iron

Walgreens opens first Hawaii store with local product partners.

FDA to hold joint meeting to evaluate Merck's OTC use of Mevacor to help lower cholesterol and prevent heart attack.

Express Scripts' Distribution Services fined $10.5 million for providing human growth hormone to athletes, entertainers.

One person arrested and $8 million in steroids and human growth hormone confiscated in raid of Brooklyn, N.Y.-based Lowen's Pharmacy.

California fires close several CVS stores

Rite Aid and dLife partner to educate and support diabetes community.

ASHP fights federal rule to report NDC numbers.

Dec. 6 is new deadline for public comments regarding electronic distribution of prescribing information for Rx drugs.

DispenseQuick is a new drug dispensing system Dispensing Solutions Inc. is selling to Amerinet doctors.

NABP moves the NAPLEX exam to new vendor.

Project QUEST is an aggressive attempt to develop performance measures that improve quality and lower costs.

The president of the American Hospital Association told health system pharmacists that first and foremost their work has to be safety and quality, but they might think about loosening up a little on method.

Hospital pharmacists are playing a more important role in the treatment of end-stage renal disease.

Staten Island hospital gives fatal overdose of fentanyl to man being treated for a broken arm.

How do you help a 45-year-old man with type 2 diabetes and chronic obstructive pulmonary disease (COPD) lose weight?

In response to a number of deaths and serious adverse events reported by patients taking Fentora, warning letters were sent to health care professionals. According to Cephalon, Inc., the deaths primarily occurred as a result of improper patient selection, improper dosing, and/or improper product substitution.

Advisory committees to the FDA recently declined to recommend any set target or range for hemoglobin levels for patients taking ESAs to combat anemia associated with chronic renal failure.

The first human thrombin approved since 1954 will soon be available. Evithrom received approval of its Biological License Application by the FDA.

CMS will soon be denying reimbursement for certain hospital-acquired conditions, according to new rules published this year.

If biogenerics are approved as biosimilars, pharmacists won't have the power to substitute them, warns head of USP

A pharmacist and health food store owner challenges the ruling by the Tennessee Board of Medical Examiners that he was improperly acting as a doctor when he recommended OTCs for diseases

After a two-month delay, the National Association of Boards of Pharmacy is again offering the North American Pharmacist Licensure Exam.

FDA's behind-the-counter drugs proposal draws mixed reactions from pharmacy associations

Independent pharmacies can survive if they find a niche in their community.

Branded pharmaceuticals, generics, OTCs, home-health products, health and beauty items

Is a new effort to codevelop drugs and diagnostics just an interesting concept or the future of drug development?